These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35473886)

  • 1. Heterogeneity of Acetylcholine Receptor Autoantibody-Mediated Complement Activity in Patients With Myasthenia Gravis.
    Obaid AH; Zografou C; Vadysirisack DD; Munro-Sheldon B; Fichtner ML; Roy B; Philbrick WM; Bennett JL; Nowak RJ; O'Connor KC
    Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35473886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    Fichtner ML; Hoarty MD; Vadysirisack DD; Munro-Sheldon B; Nowak RJ; O'Connor KC
    PLoS One; 2022; 17(3):e0264489. PubMed ID: 35290370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities.
    Rose N; Holdermann S; Callegari I; Kim H; Fruh I; Kappos L; Kuhle J; Müller M; Sanderson NSR; Derfuss T
    Acta Neuropathol; 2022 Nov; 144(5):1005-1025. PubMed ID: 36074148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology.
    Pham MC; Masi G; Patzina R; Obaid AH; Oxendine SR; Oh S; Payne AS; Nowak RJ; O'Connor KC
    Acta Neuropathol; 2023 Aug; 146(2):319-336. PubMed ID: 37344701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
    Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
    J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.
    Leite MI; Jones M; Ströbel P; Marx A; Gold R; Niks E; Verschuuren JJ; Berrih-Aknin S; Scaravilli F; Canelhas A; Morgan BP; Vincent A; Willcox N
    Am J Pathol; 2007 Sep; 171(3):893-905. PubMed ID: 17675582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis.
    Masi G; Pham MC; Karatz T; Oh S; Payne AS; Nowak RJ; Howard JF; Guptill JT; Juel VC; O'Connor KC
    Ann Clin Transl Neurol; 2023 May; 10(5):825-831. PubMed ID: 36924454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
    Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A
    Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of nicotinic acetylcholine receptor subunits in HEp-2 cells for immunodetection of autoantibody specificities in sera from Myasthenia gravis patients.
    George S; Noack M; Vanek M; Rentzsch J; Röber N; Conrad K; Roggenbuck D; Küpper JH
    Clin Hemorheol Microcirc; 2015; 61(2):385-96. PubMed ID: 26410878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.
    Yan C; Li W; Song J; Feng X; Xi J; Lu J; Zhou S; Zhao C
    Pediatr Neurol; 2019 Sep; 98():74-79. PubMed ID: 31307830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody of NRIP, a novel AChR-interacting protein, plays a detrimental role in myasthenia gravis.
    Tsai LK; Chen IH; Chao CC; Hsueh HW; Chen HH; Huang YH; Weng RW; Lai TY; Tsai YC; Tsao YP; Chen SL
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):665-676. PubMed ID: 33773096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation in myasthenia gravis plasma by Torpedo acetylcholine receptor liposomes.
    DuPont BL; Koethe SM; McQuillen MP
    Immunol Invest; 1985 Oct; 14(5):415-20. PubMed ID: 4077155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the classical complement pathway in myasthenia gravis with acetylcholine receptor antibodies.
    Ozawa Y; Uzawa A; Onishi Y; Yasuda M; Kojima Y; Kuwabara S
    Muscle Nerve; 2023 Nov; 68(5):798-804. PubMed ID: 37705312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice.
    Morgan BP; Chamberlain-Banoub J; Neal JW; Song W; Mizuno M; Harris CL
    Clin Exp Immunol; 2006 Nov; 146(2):294-302. PubMed ID: 17034582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis.
    Marcuse F; Brandts L; Moens D; Damoiseaux J; Hochstenbag M; Hoeijmakers JGJ; Maessen JG; De Baets M
    Eur J Neurol; 2022 Apr; 29(4):1187-1197. PubMed ID: 34967067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: the role of complement at the neuromuscular junction.
    Howard JF
    Ann N Y Acad Sci; 2018 Jan; 1412(1):113-128. PubMed ID: 29266249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.
    Hoffmann S; Waters P; Jacobson L; Schuelke M; Stenzel W; Ruck T; Lehnerer S; Stascheit F; Preuße C; Meisel A
    Neuromuscul Disord; 2023 Feb; 33(2):139-144. PubMed ID: 36746691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical need for clustered AChR cell-based assay testing of seronegative MG.
    Masi G; Li Y; Karatz T; Pham MC; Oxendine SR; Nowak RJ; Guptill JT; O'Connor KC
    J Neuroimmunol; 2022 Jun; 367():577850. PubMed ID: 35366559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.